Level C· Early human research exploring benefitsProspective StudyPubMedOpen access

940 nm diode laser induced differentiation of human adipose derived stem cells to temporomandibular joint disc cells.

Karic V., Chandran R., Abrahamse H.

Prospective Study on Disc Degeneration, published in BMC Biotechnol (2022) — summary generated from the PubMed abstract.

Open my reading list
Level C· Early human research exploring benefitsEvidence level of this study

Early human evidence such as case series or small samples is exploring possible benefits.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Prospective Study
Journal
BMC Biotechnol (2022)
Country
England
Reported sample size
—
Source database
PubMed
PMID
36038860
PMCID
PMC9422155
DOI
10.1186/s12896-022-00754-6
Citations
3

Abstract (original English)

Background Temporomandibular disorder (TMD) refers to a group of disorders that affect temporomandibular joint (TMJ) and its associated muscles with very limited treatment options. Stem cell research is emerging as one of the promising fields in the treatment of degenerative diseases. The ability of human adipose derived stem cells to differentiate into many cell types is driving special interest in several disease management strategies. Photobiomodulation has enhanced the role of these stem cells through their ability to promote cell proliferation and differentiation. Hence, this study examined the differentiation potential of human adipose derived stem cells (ADSCs) into fibroblasts and chondrocytes using a 940 nm diode laser for possible TMD therapy. Materials and methods ADSCs were cultured at different seeding densities and for different time intervals. After irradiation at 24, 48, 72 h, 1, 2 and 3 weeks, ADSC viability and morphological changes were assessed in groups with and without basic fibroblast growth factor. Additionally, the level of adenosine triphosphate (ATP) in the cells was also recorded. The differentiated fibroblasts and chondrocytes were characterized with flow cytometry and immunofluorescence techniques, at 1- and 2-weeks post-irradiation. Results Increased ATP proliferation and cell viability above 90% were observed in all post-irradiation experimental

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.

Evidence level

Early human evidence such as case series or small samples is exploring possible benefits.

How we grade evidence
Adenosine TriphosphateCell DifferentiationCells, CulturedHumansLasers, SemiconductorStem CellsTemporomandibular Joint Disc

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research